Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin safety study of KTZ-S 2% in healthy Japanese adult males
jRCT2031220345Completed
- Sponsor
- SEREN Pharmaceuticals
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ketoconazole in seborrheic dermatitis (SD), sponsored by SEREN Pharmaceuticals. Primary endpoints: Patch test outcomes - skin irritation, Photopatch test outcomes - solar urticaria and 4 more. Started Sep 2022; status: completed.
02
Drugs
ketoconazole
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on jRCT2031220345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220345.